All claims submitted to a Medicare Part D plan, regardless of whether Medicare Part D is the primary payer, secondary payer, or otherwise, must be submitted with the Medicare Part D RXBIN and RXPCN on the member’s ID card. CVS Caremark does not require coordination of benefits for Medicare Part D plans to process through a separate BIN.

*Please see attached PDF for more information.

Thank you for being a valued supplier and for updating your CVS Health pharmacy supplier profile for consideration to participate in CVS Health’s Diverse Retail Pharmacy Program.

Angel Flight Marketing Services, a third-party market research firm, will be helping CVS Health collect diversity certifications from our valued suppliers and providing technical assistance to independent retail pharmacy CVS Health suppliers without a current diversity certification indicating minority- or woman-owned business status.

Per the 2016 Caremark Provider Manual, unless otherwise specified, Provider must notify Caremark in writing within ten (10) business days of any changes in the documentation and other information provided to Caremark in connection with enrolling as a Provider, including but not limited to, changes in credentialing or quality management initiatives, changes in name, telephone number, fax number, services, or ownership. Provider must notify Caremark in the event of a change in the pharmacy’s physical location, prior to the change.

Effective January 1, 2017, CVS Caremark® will exclude coverage for all new-to-market unapproved products and certain existing unapproved products that may be marketed contrary to the Federal Food, Drug, and Cosmetic Act (FFDCA). Coverage will remain for select unapproved products that are legally marketed1 or deemed clinically necessary (e.g., because no alternatives exist).

*Please see attached PDF for more information.

To comply with new regulations from the Centers for Medicaid and Medicare Services (CMS), most Medicare Part D Plans and some commercial plans will be implementing new edits to help manage opioid use within their Medicare populations.

*Please see attached PDF for more information.